Search research articles
Contact Us
Filters
Showing results (181-190 of 199) with videos related to
Page
of 20
Sort By:
Angewandte Chemie (International Ed. in English)
|
January 31, 2019
A Single-Atom Nanozyme for Wound Disinfection Applications
Bolong Xu, Hui Wang, Weiwei Wang, et al.
Developmental Biology
|
November 24, 2025
Reprogramming our fate: a postdoctoral reflection on current challenges and prospects for developmental biology
Ben Dillon Cox, Hailong Yang, Joshua Moore, et al.
Obesity (Silver Spring, Md.)
|
May 19, 2023
Targeting peroxisome proliferator-activated receptor γ proteasomal degradation by magnolol is a potential avenue for adipogenesis-mediated metabolic homeostasis
Peng-Long Li, Mei Li, Zhenya Wang, et al.
Journal of Lipid Research
|
May 31, 2025
Hepatoprotective drug screening identifies daclatasvir, a promising therapeutic candidate for MASLD by targeting PLIN2
Rui Shu, Song Tian, Weiyi Qu, et al.
Cardiovascular Research
|
February 14, 2026
Identification of ALDH1A2-mediated cardioprotective benefits in myocardial ischaemia-reperfusion injury
Wei Li, Siyi Zhou, Jiayi Liu, et al.
Frontiers in Cardiovascular Medicine
|
March 31, 2023
A high-throughput drug screening identifies luteolin as a therapeutic candidate for pathological cardiac hypertrophy and heart failure
Zhenya Wang, Wei Shi, Taibo Wu, et al.
Hepatology (Baltimore, Md.)
|
July 17, 2021
The E3 Ubiquitin Ligase Ring Finger Protein 5 Ameliorates NASH Through Ubiquitin-Mediated Degradation of 3-Hydroxy-3-Methylglutaryl CoA Reductase Degradation Protein 1
Qin Yang, Xi Chen, Yanfang Zhang, et al.
Hepatology (Baltimore, Md.)
|
June 16, 2021
TNFAIP3 Interacting Protein 3 Is an Activator of Hippo-YAP Signaling Protecting Against Hepatic Ischemia/Reperfusion Injury
Junjie Zhou, Manli Hu, Meiling He, et al.
The Journal of Clinical Investigation
|
January 11, 2024
TRIM56 protects against nonalcoholic fatty liver disease by promoting the degradation of fatty acid synthase
Suowen Xu, Xiumei Wu, Sichen Wang, et al.
Cell Metabolism
|
September 3, 2021
Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart disease
Wenxin Wang, Manli Hu, Hui Liu, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 199) with videos related to
Sort By:
Page
of 20
Angewandte Chemie (International Ed. in English)
|
January 31, 2019
A Single-Atom Nanozyme for Wound Disinfection Applications
Bolong Xu, Hui Wang, Weiwei Wang, et al.
Developmental Biology
|
November 24, 2025
Reprogramming our fate: a postdoctoral reflection on current challenges and prospects for developmental biology
Ben Dillon Cox, Hailong Yang, Joshua Moore, et al.
Obesity (Silver Spring, Md.)
|
May 19, 2023
Targeting peroxisome proliferator-activated receptor γ proteasomal degradation by magnolol is a potential avenue for adipogenesis-mediated metabolic homeostasis
Peng-Long Li, Mei Li, Zhenya Wang, et al.
Journal of Lipid Research
|
May 31, 2025
Hepatoprotective drug screening identifies daclatasvir, a promising therapeutic candidate for MASLD by targeting PLIN2
Rui Shu, Song Tian, Weiyi Qu, et al.
Cardiovascular Research
|
February 14, 2026
Identification of ALDH1A2-mediated cardioprotective benefits in myocardial ischaemia-reperfusion injury
Wei Li, Siyi Zhou, Jiayi Liu, et al.
Frontiers in Cardiovascular Medicine
|
March 31, 2023
A high-throughput drug screening identifies luteolin as a therapeutic candidate for pathological cardiac hypertrophy and heart failure
Zhenya Wang, Wei Shi, Taibo Wu, et al.
Hepatology (Baltimore, Md.)
|
July 17, 2021
The E3 Ubiquitin Ligase Ring Finger Protein 5 Ameliorates NASH Through Ubiquitin-Mediated Degradation of 3-Hydroxy-3-Methylglutaryl CoA Reductase Degradation Protein 1
Qin Yang, Xi Chen, Yanfang Zhang, et al.
Hepatology (Baltimore, Md.)
|
June 16, 2021
TNFAIP3 Interacting Protein 3 Is an Activator of Hippo-YAP Signaling Protecting Against Hepatic Ischemia/Reperfusion Injury
Junjie Zhou, Manli Hu, Meiling He, et al.
The Journal of Clinical Investigation
|
January 11, 2024
TRIM56 protects against nonalcoholic fatty liver disease by promoting the degradation of fatty acid synthase
Suowen Xu, Xiumei Wu, Sichen Wang, et al.
Cell Metabolism
|
September 3, 2021
Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart disease
Wenxin Wang, Manli Hu, Hui Liu, et al.
Page
of 20